Penicillin-resistant pneumococcal meningitis: High antibiotic exposure impedes new vaccine protection

Epidemiology and Infection

Volumn 133, Issue 3, 2005, Pages 493-501

  Temime, Laura ^a,d   Boelle P Y ^a,b   Valleron, A J ^a,b   Guillemot, D ^c  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSTITUT PASTEUR   (France)

^d Bioinformatique et Chimie Moléculaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; PENICILLIN G; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT; BACTERIAL VACCINE; VACCINE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CONJUGATE; DATA ANALYSIS; DRUG EFFICACY; DRUG EXPOSURE; FRANCE; HUMAN; MATHEMATICAL MODEL; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; UNITED STATES; VACCINE PRODUCTION; ADOLESCENT; CHILD; DRUG EFFECT; FEMALE; IMMUNOLOGY; INCIDENCE; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; STATISTICAL MODEL; VACCINATION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; MODELS, STATISTICAL; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION; VACCINES, CONJUGATE;

EID: 20844434011     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268804003565     Document Type: Article

References (36)

1. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337: 970-976.
2. Perrocheau A, De Benoist AC, Six C, Goulet V, Decludt B, Levy-Bruhl D. Epidemiology of bacterial meningitis in France in 1999 [in French]. Ann Med Interne (Paris) 2002; 153: 311-317.
3. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 (Suppl 2): S81-93.
4. Geslin P, Fremaux A, Sissia G, Spicq C. Streptococcus pneumoniae: serotypes, invasive and antibiotic resistant strains. Current situation in France [in French]. Presse Med 1998; 27 (Suppl 1): 21-27.
5. Fenoll A, Jado I, Vicioso D, Perez A, Casal J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol 1998; 36: 3447-3454.
6. Arditi M, Mason Jr EO, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102: 1087-1097.
7. Pacheco TR, Cooper CK, Hardy DJ, Betts RF, Bonnez W. Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis. Am J Med 1997; 102: 303-305.
8. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J 1995; 14: 885-890.
9. Sloas MM, Barrett FF, Chesney PJ, et al. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1992; 11: 662-666.
10. O'Brien KL, Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 2003; 21: 1815-1825.
11. Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 2003; 22: 532-540.
12. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-1746.
13. Pelton SI, Marchant CD, Christiansen D, Loughlin A. Temporal changes in serotype distribution and antimicrobial resistance among isolates of S. pneumoniae (SP) in Massachussets [abstract 890]. In: Program and abstracts of the 43rd Interscience Conference on Antimocrobial Agents and Chemotherapy (ICAAC). Chicago, IL: American Society for Microbiology, 2003.
14. Spratt BG, Greenwood BM. Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 2000; 356: 1210-1211.
15. von Kries R, Siedler A, Schmitt HJ, Reinert RR. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 2000; 31: 482-487.
16. Elseviers M, Ferech M, VanderStichele R, Goossens H. Consumption of antibiotics in ambulatory care in Europe, 2003 (http://www.uia.ac.be/esac/).
17. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-1853.
18. Karlowsky JA, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST surveillance program (1998-2002). Clin Infect Dis 2003; 36: 963-970.
19. Guillemot D, Maison P, Carbon C, et al. Trends in antimicrobial drug use in the community- France, 1981-1992. J Infect Dis 1998; 177: 492-497.
20. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data 2002: 1-32.
21. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci USA 1997; 94: 6571-6576.
22. Dagan R, Sikuler-Cohen M, Zamir O, Janco J, Givon-Lavi N, Fraser D. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J 2001; 20: 951-958.
23. Geslin P, Fremaux A, Sissia G. Epidemiology of Streptococcus pneumoniae antibiotic resistance [in French]. Arch Pediatr 1996; 3: 93S-95S.
24. Temime L, Boelle PY, Courvalin P, Guillemot D. Bacterial resistance to penicillin G by decreased affinity of penicillin-binding proteins: a mathematical model. Emerg Infect Dis 2003; 9: 411-417.
25. Raymond J, Le Thomas I, Moulin F, Commeau A, Gendrel D, Berche P. Sequential colonization by Streptococcus pneumoniae of healthy children living in an orphanage. J Infect Dis 2000; 181: 1983-1988.
26. Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Internat Stat Rev 1994; 2: 229-243.
27. Temime L, Guillemot D, Boelle PY. Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob Agents Chemother 2004; 48: 2206-2213.
28. McCormick AW, Whitney CG, Farley MM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003; 9: 424-430.
29. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996; 348: 271-272.
30. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344: 403-409.
31. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 1999; 5: 336-345.
32. Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002; 50 (Suppl S1): 25-37.
33. Bronzwaer SL, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278-282.
34. Hausdorff WP, Yothers G, Dagan R, et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 2002; 21: 1008-1016.
35. Hansman D, Morris S, Gregory M, McDonald B. Pneumococcal carriage amongst Australian aborigines in Alice Springs, Northern Territory. J Hyg (Lond) 1985; 95: 677-684.
36. Rieux V, Carbon C, Azoulay-Dupuis E. Complex relationship between acquisition of beta-lactam resistance and loss of virulence in Streptococcus pneumoniae. J Infect Dis 2001; 184: 66-72.